Equity
€574,618 ▲ 1.6%
MICROBELCAPS has made a profit without a break since 2017.
MICROBELCAPS
Lifetime
20 annual accounts with figures on one time axis, 30 filings since 1996peak €2.2m (2016)
€595,134▼ 35.1%
lowest -€20,208 (2006)
€9,025▼ 94.3%
peak €574,618 (2025)
€574,618▲ 1.6%
€252,436▼ 37.3%
peak 6.2 FTE (2014)
4.4 FTE▼ 6.4%
Board8 names since 2021
4 directorsS.A. Laboratoires S.M.B. and 3 others
Owners
Documentsfilings and deeds
08-07-202623 days before the deadline
2025financial year
Turnover from €916,925 to €595,134Gross margin from €577,621 to €354,668Result from €159,083 to €9,025Debts from €402,909 to €252,436Cash from €309,521 to €166,308
Key points
from the 2025 annual accountsResult
€9,025 ▼ 94.3%
The result fell in 2025 from €159,083 to €9,025.
Staff
5 employees on 31-12-2025
In 2025, 17 people joined and 16 left.
Payment terms
29 days to suppliers
MICROBELCAPS pays its suppliers 5 days later than in 2024. Customers pay 32 days later.
Filings
30 annual accounts since 1996
Two of the last ten came late. The 2019 accounts came latest: 14 days after the end of the period.
At the same address
10 companies
Checked score
95
Excellent
Financially stronger than 58% of micro companies in pharmaceuticals (NACE 21)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.4% across 152 companies (NACE 21, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.2%▲ +0.1 percentage points vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025highest value
07-2025: 0.1%▼ -0.1 percentage points vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: < 0.1%▼ -0.1 percentage points vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026lowest value
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Size: turnover €595,134, 4.4 FTE, total assets €827,054
lowers risk
Liquidity: current ratio 3.25, cash €166,308
Equity €574,618 (69.5% of total assets)
Founded in 1995
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro). It does better than 77% of them on solvency, 74% on liquidity, 53% on profitability and 28% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 17,041 companies had the same profile as MICROBELCAPS has now. Each dot stands for 43 companies, two years later.
94.4%
were still trading
4.9%
stopped another way
0.5%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of MICROBELCAPS itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,041 companies, not a prediction for MICROBELCAPS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.25 (2.45 in 2024), above the usual 1.5. Short-term debt is 16% and cash 20.1% of total assets. 30.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
23 days early
2024
35 days early
2023
28 days early
2022
17 days early
2021
12 days late
2020
37 days early
2019
14 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 16 days before the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
SA
S.A. Laboratoires S.M.B.
Director, since 10-06-2021
VC
VENTURE COACHING
Director, Eric FELLER, since 10-06-2021
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0454591191
Amendment of the articles
Registered office clause: Liège (4031-Angleur, Allée des Noisetiers 2D · Gazette deed
Appointment: Marie-Anne HENRARD (director)
General meeting of 29-06-2023 · Gazette deed
1 director resigning
Pascale AZZAM · Permanent representatives: Lucas FOTSING and Bruno STREEL · General meeting of 22-06-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MICROBELCAPS Liège | €0.8m | €0.4m | 69.5% | 4.4 |
| NAQI Halen | €1.2m | €0.5m | 8.5% | 6.3 |
| Brussels Medical Center Oostkamp | €0.3m | €0.2m | 5.8% | 4.3 |
| Titamed Kontich | €1.4m | €1.4m | 32.3% | 6.1 |
| CEREPHARMA Ath | €1.5m | €0.6m | 61.2% | 6.3 |
| PHARMA 2424 Charleroi | €0.6m | €0.2m | 55.3% | 1.1 |
| VITONA Ghent | €0.9m | €0.2m | 93.0% | - |
These companies have the same main activity as MICROBELCAPS: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209). They are comparable in size and age: total assets between €272,000 and €1.5m, founded between 1986 and 2011.
Official details
Source: KBO- Status
- Active since 07-02-1995Normal situation
- Registered office
- 11 active companies are registered at this addressSource: KBO register, as of 9 November 2026.
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209and 2 others
- Joint committees
- 116Chemical industry
- 207White-collar workers in the chemical industry · annual accounts 2025
- Establishment unit
- 2.102.983.8534031 Liège, since 13-03-1995
- Financial year end
- 31 December
- Peppol
- Reachable since 16-06-2026
Annual accounts 2025
- €827,054▼ 14.6%
- Employeeson 31-12-2025
- 5=
- Filing
- Filed on 08-07-2026, 23 days before the end of the filing period
Insights on MICROBELCAPS
MICROBELCAPS has existed since 1995. Turnover fell from €2.1m in 2018 to €437,674 in 2019. The accounts now follow the micro format, last year the full format.
Solvency rose in 2025 from 58.4% to 69.5% because of the retained profit and lower debts.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MICROBELCAPS
- What is the company number of MICROBELCAPS?
- The company number of MICROBELCAPS is 0454.591.191. The VAT number is the same number with BE in front: BE 0454.591.191.
- Where is MICROBELCAPS based?
- The registered office is at Allée des Noisetiers 2, 4031 Liège.Company details
- What does MICROBELCAPS do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
- What is the legal form of MICROBELCAPS?
- MICROBELCAPS is a public limited company (NV).
- When was MICROBELCAPS founded?
- MICROBELCAPS was founded on 07-02-1995.
- Is MICROBELCAPS still active?
- Yes, MICROBELCAPS is an active enterprise in the KBO register.
- How many employees does MICROBELCAPS have?
- MICROBELCAPS had an average of 4.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does MICROBELCAPS fall under?
- In its 2025 annual accounts, MICROBELCAPS states joint committees 116 (Chemical industry) and 207 (White-collar workers in the chemical industry).
- What is the turnover of MICROBELCAPS?
- The turnover of MICROBELCAPS was €595,134 in financial year 2025, according to the filed annual accounts.
- Is MICROBELCAPS profitable?
- In financial year 2025, MICROBELCAPS made a profit of €9,025.
- Where can I find the annual accounts of MICROBELCAPS?
- MICROBELCAPS filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MICROBELCAPS due?
- MICROBELCAPS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.